Unipharm Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Unipharm

Access the complete profile.

Unipharm Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	4242 Drugs & Druggists' Sundries Merchant Wholesalers
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	350 Fifth Avenue, 67th Fl. New York, NY 10118

Note: Revenues for privately held companies are statistical evaluations.


Unipharm's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Unipharm's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Unipharm is classified as operating in the Drugs & Druggists' Sundries Merchant Wholesalers industry, NAICS Code 4242.

Unipharm Annual Revenue and Growth Rate

Unipharm	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$100 - $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Unipharm's revenues are gauged from an analysis of company filings.

Unipharm's Income Statement (based on Industry Averages)

Unipharm P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Unipharm is developing and marketing. Unipharm's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
TRIOFLEX pharmaceuticals and dietary supplements	01/22/2024
GRIPPEX pharmaceutical preparations for the treatment and prevention of inflammatory diseases of various etymology, namely, antibacterial pharmaceuticals, anti-inflammatory pharmaceuticals, antibiotics, antiviral agents, topical gels and ointments for dermatological and ophthalmological use, topical gels for oral cavity, gels for gums, creams for dermatological and ophthalmological use; vitamin and mineral supplements	08/22/2023
RELORN Pharmaceuticals for pain relief and fever reduction	02/08/2023

See all trademarks and details in the Full Report.

Market Share of Unipharm's Largest Competitors

A competitive analysis shows these companies are in the same general field as Unipharm, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
AMERISOURCEBERGEN	Conshohocken, PA	100
MCKESSON	Irving, TX	58
CARDINAL HEALTH 119	Dublin, OH	42
TAKEDA PHARMACEUTICALS AMERICA	Lexington, MA	31
CATALENT PHARMA SOLUTIONS	Somerset, NJ	13
OWENS & MINOR DISTRIBUTION	Mechanicsville, VA	11
J M SMITH	Spartanburg, SC	3
DAIICHI SANKYO	Basking Ridge, NJ	3
HIKMA PHARMACEUTICALS USA	Berkeley Heights, NJ	2

Nearby Competitors

These companies are similar in business line and location to Unipharm. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
BREAKTHRU BEVERAGE GROUP	New York, NY	100
PERNOD RICARD USA	New York, NY	25
SUNBELT BEVERAGE CO LLC D/B/A BREAKTHRU BEVERAGE GROUP	New York, NY	25
MILLWORK HOLDINGS	New York, NY	8
JEAN PHILIPPE FRAGRANCES LLC.	New York, NY	5
REMY COINTREAU USA	New York, NY	4
EASY PICKINS	New York, NY	3
MAMIYE SALES	New York, NY	2
UNIPHARM	New York, NY	1
KURT S ADLER	New York, NY	1

Future Competition: Unipharm's Fastest Growing Competitors

These companies are in the same general field as Unipharm and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)